Blindness, Acquired
8
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
AI-Powered Artificial Vision for Visual Prostheses
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
Advanced Spatiomotor Rehabilitation for Navigation in Blindness & Visual Impairment
Effects of Transcranial Direct Current Stimulation With Proprioceptive Training in Blind People
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.